PipelineReview.com - Biotech News & Online Store - VaxOnco to Sponsor Phase I Trial of a Folate Receptor Alpha-targeted Breast/Ovarian Cancer Therapeutic Vaccine That Recently Received Investigational New Drug Approval From FDA ovarian cancer

http://www.pipelinereview.com/index.php/2011072643918/Vaccines/VaxOnco-to-Sponsor-Phase-I-Trial-of-a-Folate-Receptor-Alpha-targeted-Breast/Ovarian-Cancer-Therapeutic-Vaccine-That-Recently-Received-Investigational-New-Drug-Approval-From-FDA.html

Sent from my iPhone